Canada markets open in 3 hours 34 minutes

Applied DNA Sciences, Inc. (APDN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.3400+0.0900 (+7.20%)
At close: 04:00PM EDT
1.3100 -0.03 (-2.24%)
After hours: 07:53PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close1.2500
Open1.2600
Bid1.2200 x 1300
Ask1.3400 x 1100
Day's Range1.2500 - 1.3800
52 Week Range0.6200 - 7.3500
Volume346,496
Avg. Volume7,748,135
Market Cap17.263M
Beta (5Y Monthly)0.07
PE Ratio (TTM)N/A
EPS (TTM)-1.9060
Earnings DateDec 07, 2022 - Dec 12, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.00
  • Business Wire

    Applied DNA and the Cornell University College of Veterinary Medicine Announce Research Collaboration to Accelerate Application of LinearDNA™ Platform for Veterinary Health Applications

    STONY BROOK, N.Y. & ITHICA, N.Y., September 08, 2022--Applied DNA Sciences, Inc. (NASDAQ: APDN) (‘Applied DNA’ or the "Company"), a leader in polymerase chain reaction ("PCR")-based technologies, and the Cornell University College of Veterinary Medicine ("CUCVM") announced the signing of a research agreement (the "Agreement") to advance LinearDNA™-based vaccine research and discovery for animal diseases with agricultural biosecurity implications. Primarily, the Agreement seeks to combine LinearD

  • Business Wire

    Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022

    STONY BROOK, N.Y., September 07, 2022--Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced it will be featured as a presenting company at the H.C. Wainwright 24th Annual Global Investment Conference on September 13, 2022, at 2:00 pm Eastern Time. The conference is being held as a hybrid in-person/virtual event from September 12 to 14, 2022.

  • Business Wire

    Applied DNA Launches Monkeypox Testing Service

    STONY BROOK, N.Y., September 06, 2022--Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, announced today that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC ("ADCL"), has launched monkeypox testing as a clinical reference laboratory testing service available to hospital systems and clinical labs located in New York State and in states that recognize New York's CLEP/CLIA certification for testing.